News
This drug led to 50% more weight loss than Wegovy in head-to-head study
While the drugs certainly contribute to weight loss and health gains, they also cause a decline in muscle that some doctors find concerning. In trials of Wegovy, up to 40% of weight loss was from a decrease in lean or fat-free mass, rather than excess fat. In addition, quitting the drugs can mean adding back the pounds.
Zepbound Beats Wegovy for Weight Loss in First Head-To-Head Trial of Blockbuster Drugs
People taking Eli Lilly's obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk's Wegovy in the first head-to-head study of the blockbuster medications. Clinical trial participants who took tirzepatide,
Bone broth has been having a moment. An increasing number of folks are including the ingredient as part of their diet, many ...
If a higher body weight is affecting your ability to get around, or you have joint pain from arthritis, it can impair your ...
4hon MSN
Meghan Trainor and her husband, Daryl Sabara, opened up about using Mounjaro — combined with a strict diet and exercise — for ...
The Trump administration on Monday singled out powerful new weight-loss drugs including Wegovy and Zepbound as targets in its ...
GLP-1 drugs achieve some of these effects by directly affecting the brain’s cravings for food, and that might also extend to ...
Health on MSN1d
How Much Water Should You Drink for Weight Loss?Research shows that drinking water can influence your appetite, metabolism, and overall calorie intake. Your water needs ...
Ever since the pharmaceutical company Novo Nordisk realized that GLP-1 drugs were useful for more than diabetes, doctors and ...
3h
The pop star was performing the 2014 hit during iHeartRadio’s KIIS-FM Wango Tango Saturday when she made the surprising ...
A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...
Weight-loss injections, or GLP-1 receptor agonists, could nearly halve the risk of obesity-related cancers, a new study finds ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback